Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. stocks close higher for fourth straight week, as oil triggers surge

Published 03/11/2016, 04:20 PM
Updated 03/11/2016, 04:30 PM
The Dow, NASDAQ and S&P 500 all surged by more than 1% on Friday

Investing.com -- U.S. stocks rose broadly on Friday closing higher for their fourth consecutive week, as crude soared to its highest level on the calendar year and investors felt the ripple effects from the European Central Bank's decision to implement a wide range of easing measures in order to stimulate growth throughout the zone.

On Friday, U.S. crude futures hit their highest level since early-December after the Paris-based International Energy Agency (IEA) said in a monthly report that it expects Non-OPEC supply to decline by 750,000 in 2016, up from previous estimates of 600,000. Shortly thereafter, crude held onto the gains after Baker Hughes said the number of oil rigs in the U.S. last week fell by nine to 480, its lowest level on record. At session-highs, WTI crude hit $41.03 a barrel on Friday, its highest amount since December 3.

The Dow Jones Industrial Average surged 218.18 or 1.28% to 17,213.31, closing at near session-highs. At one point on Friday, the Dow reached its highest level since January 6. The NASDAQ Composite index gained 86.31 or 1.85% to 4,748.47, while the S&P 500 Composite index added 32.62 or 1.64% to 2,022.19. On the S&P 500, all 10 sectors closed in the green, as stocks in the Energy, Financials and Health Care industries led. In total, seven sectors closed at least 1% or higher in Friday's session. For the week, the S&P 500 rose by more than 1%.

The top performer on the Dow was Pfizer Inc (NYSE:PFE) (NYSE:PFE), which jumped 0.89 or 2.99% to 30.48 after the U.S. Food and Drug Administration (FDA) approved the expanded use of Xalkori, the company's drug developed to treat lung cancer. The drug is being marketed to treat non-small cell lung cancer for patients with ROS1 gene mutations. The worst performer was Wal-Mart Stores Inc (NYSE:WMT), which lost 0.33 or 0.49% to 67.08. Wal-Mart (NYSE:WMT) finished just below Procter & Gamble Company (NYSE:PG), which fell 0.37 or 0.45% to 81.91, after its chief rival Colgate-Palmolive Company (NYSE:CL) increased its quarterly dividend by 3% to 0.39.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The biggest gainer on the NASDAQ was Biomarin Pharmaceutical Inc (NASDAQ:BMRN), which added 4.55 or 5.44% to 88.15. The worst performer was Mattel Inc (NASDAQ:MAT), which lost 0.60 or 1.77% to 33.03. Despite the mild losses, shares in the toy giant are up nearly 30% over the last year as sales among its iconic Barbie line have recovered in recent months.

The top performer on the S&P 500 was Devon Energy Corporation (NYSE:DVN), which gained 2.36 or 10.50% to 24.84. As oil prices have fallen precipitously over the last year, shares in Devon Energy (NYSE:DVN) have tumbled more than 63%. The worst performer was PEPCO Holdings Inc (NYSE:POM), which lost 1.83 or 7.55% to 22.42. It came after the people's council for the District of Columbia rejected the latest merger between Exelon (NYSE:EXC) and Pepco, the public utility supplying electric power to the city of Washington D.C.

On the New York Stock Exchange, advancing issues outnumbered declining ones by a 2,652-488 margin.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.